Maltese government to lower medicine registration prices

Maltese government to lower medicine registration prices


Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
+

The Malta Chamber for Small and Medium Enterprises (GRTU), the HealthCare Trade Section of the Malta Chamber of Commerce and Enterprise and the Malta Federation of Industry had concluded negotiations with the government on aspects related to medicine registration and availability in Malta, Malta Media news reported.

The government and medicine importers have agreed upon a simple system for the registration of medicines that have already been registered in other countries of the European Union. The parties involved in the negotiations said through the agreement the Maltese market is expected to be supplied with a vaster range of medicines at competitive prices. Addressing a press conference, Parliamentary Secretary Tonio Fenech stated that the government is lowering the prices of the registration of medicinal products to provide a wider range of medicinal product on the Maltese markets and ensure that higher registration prices are not used as an excuse to overcharge consumers. Fenech attributed the high price of medicines to importers who providing Malta with expensive medicine to increase their profits as opposed to the lack of supply. In July, the government and GRTU were reported to have found a solution to the problems of accessibility and availability of affordable medicinal products, but the solution was not revealed. Meanwhile, one of the solutions discussed in the agreement includes a one-time 50 Matese pounds annual registration fee, replacing a series of fees. Besides, variations fees which were levied each and every time a particular medicine underwent small changes in dosage, ingredients or packaging have now been abolished. An important aspect of the agreement is that the information leaflet of each medicine may now be made available in either of the national official languages or both.

Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
+